Tajikistan Health News
SEE OTHER BRANDS

Fresh news on health and wellness in Tajikistan

Promaxo Announces Participation in the 35th Annual Piper Sandler Healthcare Conference

OAKLAND, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Promaxo, Inc. (“Promaxo” or the “Company”), a medical imaging, robotics, and AI technology company, today announced Amit Vohra, Chief Executive Officer, will participate at the 35th Annual Piper Sandler Healthcare Conference from November 28 - 30, 2023.

Promaxo will give a corporate presentation on Tuesday, November 28 at 12:30 PM ET and host investor 1x1 meetings, which can be requested through Piper Sandler.

About Promaxo, Inc.
Promaxo was founded by a team of entrepreneurs and healthcare innovators to develop a minimally-invasive and patient-centric MRI and robotic platform. Based in Oakland, California, and backed by over 200 patents, the Company’s mission is to improve lives through state-of-the-art medical imaging, robotics and AI capabilities. With a compact and adaptable MRI, Promaxo is redefining the standard of care by improving the quality and speed of patient diagnosis and interventions. The Company has formed numerous long-term and strategic partnerships with investor groups and corporation as it drives commercialization of the Promaxo MRI system.

To learn more about the technology behind the MRI system and its scope, please visit: Promaxo.com.
LinkedIn: Promaxo
Twitter: @Promaxo
Facebook: Promaxo

Investors
Gilmartin Group
Vivian Cervantes
e: IR@promaxo.com


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service